DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Debt History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Debt | ₹7,734 Cr | ₹4,677 Cr | ₹2,002 Cr | ₹1,347 Cr | ₹3,385 Cr |
What is the latest Total Debt ratio of DR REDDYS LABORATORIES ?
| Year | Total Debt |
|---|---|
| Mar2026 | ₹7,734 Cr |
| Mar2025 | ₹4,677 Cr |
| Mar2024 | ₹2,002 Cr |
| Mar2023 | ₹1,347 Cr |
| Mar2022 | ₹3,385 Cr |
How is Total Debt of DR REDDYS LABORATORIES Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,734 Cr | 65.38 | |
| Mar2025 | ₹4,677 Cr | 133.60 | |
| Mar2024 | ₹2,002 Cr | 48.60 | |
| Mar2023 | ₹1,347 Cr | -60.20 | |
| Mar2022 | ₹3,385 Cr | - | |
Compare Total Debt of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹111,795.5 Cr | 0.8% | 3.9% | 1.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,704.0 Cr | -0.5% | 3.9% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,684.0 Cr | -3.1% | -0.1% | 0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,093.0 Cr | 3.1% | 6.7% | 45.5% | Stock Analytics | |
| CIPLA | ₹117,699.0 Cr | 1.4% | 4.8% | -2.5% | Stock Analytics | |
| MANKIND PHARMA | ₹102,844.0 Cr | 0.6% | 7.3% | 10.3% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 0.8% |
3.9% |
1.5% |
| SENSEX | 1% |
2.9% |
-6.1% |
You may also like the below Video Courses